A new flu vaccine using messenger RNA technology is available at some King Soopers pharmacies in Colorado, offering adults 50 ...

Moderna and Merck prepare FDA submission for their individualized mRNA melanoma vaccine.The company reported an annual ...

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was ...

Researchers redesigned lipid nanoparticles to cut liver accumulation of locally injected mRNA by up to eighty-fold in mice ...

A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that ...

Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the ...

Coca-Cola Co. (KO) and Visa Inc. (V) hit fresh 52-week highs on Thursday as positive company news lifted investor sentiment.

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA ...

Explore the potential of a personalized mRNA vaccine that targets specific cancer mutations for advanced melanoma treatment.

- Moderna's stock surged 500% driven by positive Phase 3 trial data for its personalized cancer vaccine intismeran autogene ...

CAMBRIDGE, MA / ACCESS Newswire / October 13, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a ...